In the pharmaceutical industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. In this video, Chief Architect, Imran Chaudhri answers some of the most frequently asked questions about the Pharma Research Hub.
Data silos and fragmented processes hinder drug safety practices for adverse event detection and reporting. Learn how MarkLogic breaks down data silos—enabling a complete view of data across pharmacovigilance operations that accelerates signal detection and simplifies regulatory reporting
With an immense amount of clinical data readily available for analytics, the challenge is to efficiently integrate disconnected data silos. Learn how data science and digital data technologies are empowering pharmaceutical organizations to bridge the gaps presented by these data silos.
MarkLogic enables Life Sciences companies to integrate all of their disparate data sets, harmonize the data, and discover new relationships among it—making it an ideal database platform for accelerating real world evidence. Learn how a multinational Fortune 50 company achieved time and cost benefits by developing a metadata catalog to more quickly find valuable assets …
I recently had a chance to catch-up with Bill Fox, MarkLogic’s new Vice President of Health Care and Life Sciences, to ask for his thoughts on a special Healthcare IT briefing he recently attended at the White House. According to Bill, the Administration is calling on technology companies to get involved in the development of fast, […]
Product, people and customer challenges – Amey Dhavle gives us an inside glimpse of a day in the life of his world as a Principal Field Engineer at MarkLogic and discusses why he’s still excited about the NoSQL database company after years of employment. While “It’s definitely not a two guys, a garage and dog setup … […]